Rohini Sharma
Overview
Explore the profile of Rohini Sharma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
3131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma R, Gulati A, Chopra K
Eur J Clin Pharmacol
. 2025 Mar;
PMID: 40080138
Purpose: The regulatory landscape in rare diseases and oncology has evolved to address unmet medical needs by implementing expedited approval pathways. The US FDA's Accelerated Approval and the EMA's Conditional...
2.
Rani V, Khosla R, Sharma R, Kunsi S, Chandran T, Ali A
J Pharm Bioallied Sci
. 2025 Feb;
16(Suppl 4):S3260-S3262.
PMID: 39927030
Background: Tobacco use remains a major public health issue, contributing to numerous oral and systemic diseases. Dental professionals are in a unique position to offer tobacco cessation support, yet many...
3.
Rzeniewicz K, Sharma R
World J Clin Oncol
. 2024 Nov;
15(11):1394-1403.
PMID: 39582617
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death globally, with 15% of cases arising on a background of non-alcoholic fatty liver disease (NAFLD). NAFLD is a heterogenous...
4.
Lopez-Lopez V, Kalt F, Zhong J, Guidetti C, Magistri P, Di Benedetto F, et al.
Langenbecks Arch Surg
. 2024 Oct;
409(1):324.
PMID: 39453520
No abstract available.
5.
Polepalle T, Mannava P, Pesala D, Sharma R, Elango A, Ghate S
J Pharm Bioallied Sci
. 2024 Sep;
16(Suppl 3):S2300-S2302.
PMID: 39346331
Aim: The present study was aimed at evaluating the variations in fibrin network patterns of the platelet-rich fibrin (PRF) procured from diabetics, non-diabetics, and smokers suffering from chronic periodontitis. Materials...
6.
Troiani A, Martinez M, Ward C, Benartzi C, Pinato D, Sharma R
Future Oncol
. 2024 Sep;
20(36):2839-2847.
PMID: 39283290
Overactivation of the JAK/STAT pathway is one of the drivers for the pathophysiology of hepatocellular carcinoma (HCC). We propose a Phase Ib study to evaluate the safety and efficacy of...
7.
Lopez-Lopez V, Kalt F, Zhong J, Guidetti C, Magistri P, Di Benedetto F, et al.
Langenbecks Arch Surg
. 2024 Sep;
409(1):277.
PMID: 39269544
Purpose: The Barcelona Clinic Liver Cancer (BCLC) staging schema is widely used for hepatocellular carcinoma (HCC) treatment. In the updated recommendations, HCC BCLC stage B can become candidates for transplantation....
8.
Qurashi M, Von Wagner C, Sharma R
J Hepatocell Carcinoma
. 2024 Aug;
11:1597-1605.
PMID: 39193064
Background And Aims: Six-monthly ultrasound surveillance for hepatocellular carcinoma (HCC) is recommended in patients with cirrhosis. Surveillance enhances early detection and improves survival. Yet, despite clear benefits, uptake remains low....
9.
Vithayathil M, Qurashi M, Vicente P, Alsafi A, Naik M, Graham A, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123437
Background: Biannual ultrasound (US) is recommended for hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis. However, US has limited sensitivity for early-stage HCC, particularly in overweight cohorts, where hepatic visualisation...
10.
Celsa C, Cabibbo G, Fulgenzi C, Battaglia S, Enea M, Scheiner B, et al.
Hepatology
. 2024 Jul;
81(3):837-852.
PMID: 39028886
Background And Aims: Unlike other malignancies, hepatic functional reserve competes with tumor progression in determining the risk of mortality from hepatocellular carcinoma (HCC). However, the relative contribution of hepatic decompensation...